From the Toronto Star:
Canada’s brand-name pharmaceutical companies should “tone down their rhetoric” and work with the Liberal government to help save Ontario’s taxpayers millions of dollars in drug costs, Health Minister George Smitherman said Friday.
Smitherman was reacting to Paul Lucas, the CEO of GlaxoSmithKline, who warned Thursday that the province’s cost-saving plan will do to Ontario’s research-based drug companies what the Diefenbaker government’s cancellation of the Avro Arrow jet fighter did to the aerospace industry. ...more
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment